Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PINC Stock Forecast 2026-2027
$28.26
Current Price
$2.34B
Market Cap
Buy 0
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to PINC Price Targets
0.0%
To High Target of $28.25
0.0%
To Median Target of $28.25
0.0%
To Low Target of $28.25
PINC Price Momentum
0.0%
1 Week Change
0.0%
1 Month Change
+25.2%
1 Year Change
0.0%
Year-to-Date Change
-1.8%
From 52W High of $28.79
+64.1%
From 52W Low of $17.23
📊 TOP ANALYST CALLS
Did PINC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Premier Inc is one of their latest high-conviction picks.
Latest PINC Stock Price Targets & Analyst Predictions
Based on our analysis of 17 Wall Street analysts, PINC has a neutral consensus with a median price target of $28.25 (ranging from $28.25 to $28.25). The overall analyst rating is Buy (6.0/10). Currently trading at $28.26, the median forecast implies a 0.0% downside. This outlook is supported by 0 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Jessica Tassan at Piper Sandler, projecting a 0.0% downside. Conversely, the most conservative target is provided by Jessica Tassan at Piper Sandler, suggesting a 0.0% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PINC Analyst Ratings
0
Buy
2
Hold
0
Sell
PINC Price Target Range
Low
$28.25
Average
$28.25
High
$28.25
Current: $28.26
Latest PINC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PINC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 5, 2025 | Piper Sandler | Jessica Tassan | Neutral | Maintains | $28.25 |
| Sep 25, 2025 | UBS | Kevin Caliendo | Neutral | Maintains | $28.25 |
| Sep 23, 2025 | Canaccord Genuity | Richard Close | Hold | Maintains | $28.25 |
| Aug 25, 2025 | Piper Sandler | Jessica Tassan | Neutral | Maintains | $28.00 |
| Aug 20, 2025 | UBS | Kevin Caliendo | Neutral | Maintains | $26.00 |
| Aug 20, 2025 | Canaccord Genuity | Richard Close | Hold | Maintains | $25.00 |
| Aug 20, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $27.00 |
| Aug 19, 2025 | B of A Securities | Michael Cherny | Underperform | Maintains | $21.00 |
| Aug 19, 2025 | Leerink Partners | Michael Cherny | Market Perform | Maintains | $26.00 |
| Jun 30, 2025 | Leerink Partners | Hold | Maintains | $N/A | |
| May 21, 2025 | Piper Sandler | Jessica Tassan | Neutral | Maintains | $24.00 |
| May 15, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $22.00 |
| May 13, 2025 | B of A Securities | Sell | Maintains | $N/A | |
| May 8, 2025 | Canaccord Genuity | Richard Close | Hold | Maintains | $22.00 |
| Feb 5, 2025 | Piper Sandler | Jessica Tassan | Neutral | Maintains | $19.00 |
| Feb 5, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $19.00 |
| Feb 5, 2025 | Canaccord Genuity | Richard Close | Hold | Maintains | $19.00 |
| Nov 6, 2024 | Canaccord Genuity | Richard Close | Hold | Maintains | $21.00 |
| Nov 6, 2024 | Barclays | Stephanie Davis | Equal-Weight | Maintains | $24.00 |
| Nov 6, 2024 | Baird | Eric Coldwell | Neutral | Maintains | $20.00 |
Premier Inc. (PINC) Competitors
The following stocks are similar to Premier Inc based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
PINC
Premier Inc
mkt cap
2.34B
Premier Inc. (PINC) Financial Data
Premier Inc. has a market capitalization of $2.34B with a P/E ratio of 166.2x. The company generates $1.00B in trailing twelve-month revenue with a -3.3% profit margin.
Revenue growth is -3.3% quarter-over-quarter, while maintaining an operating margin of +11.4% and return on equity of +0.9%.
Valuation Metrics
Market Cap
$2.34B
Enterprise Value
$2.62B
P/E Ratio
166.2x
PEG Ratio
-2.4x
Price/Sales
2.3x
Growth & Margins
Revenue Growth (YoY)
-3.3%
Gross Margin
+71.1%
Operating Margin
+11.4%
Net Margin
-3.3%
EPS Growth
-75.2%
Financial Health
Cash/Price Ratio
+1.9%
Current Ratio
0.6x
Debt/Equity
21.4x
ROE
+0.9%
ROA
+3.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Premier Inc. (PINC) Business Model
About Premier Inc.
What They Do
Optimizes healthcare delivery and outcomes.
Business Model
The company generates revenue by providing integrated data analytics, consulting, and services to healthcare providers. Through its comprehensive offerings, including supply chain services and performance improvement programs, Premier helps healthcare institutions enhance service delivery and reduce costs.
Additional Information
Premier Inc. plays a significant role in the healthcare sector, impacting hospitals and health systems. It focuses on advancements in value-based care and population health management while contributing to industry standards and innovation in healthcare.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
2,700
CEO
Mr. Michael J. Alkire
Country
United States
IPO Year
2013
Website
www.premierinc.comPremier Inc. (PINC) Latest News & Analysis
Latest News
Quick Summary
AAAD and PINC aim to enhance total return by focusing on both current income and capital appreciation strategies.
Why It Matters
AAAD and PINC's focus on maximizing total return signals potential for income and growth, attracting investors seeking balanced investment strategies in current markets.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Wilcrest Pharmaceuticals secured a national purchasing agreement with Premier, Inc. for outsourced compounded preparations, effective April 1, 2026, offering special pricing for Premier members.
Why It Matters
Wilcrest Pharma's new agreement with Premier, Inc. enhances revenue potential and market access, positioning the company favorably in the competitive pharmaceutical landscape.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Ethisphere Names Premier as One of the 2026 World's Most Ethical Companies® for 19th Consecutive Year
2 months ago
Quick Summary
Premier, Inc. has been named one of the 2026 World's Most Ethical Companies® by Ethisphere, marking its 19th recognition in 20 years. It is the sole honoree in the Business Services category.
Why It Matters
Recognition as one of the World’s Most Ethical Companies can enhance Premier, Inc.'s reputation, attracting investors and potentially boosting stock performance due to increased trust and brand loyalty.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Convatec has secured two group purchasing agreements with Premier, Inc. for enterostomal therapy products, effective April 1, 2026, enabling special pricing for Premier members.
Why It Matters
Convatec's new agreements with Premier enhance its market presence and revenue potential in enterostomal therapy, signaling growth opportunities that can positively impact stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
AOP Health US, LLC secured a national group purchasing agreement with Premier, Inc. for its drug Rapiblyk® effective August 1, 2025, ensuring nationwide availability and special pricing for members.
Why It Matters
AOP Health's agreement with Premier enhances market access for Rapiblyk®, potentially boosting sales and solidifying its position in critical care, which could positively impact stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Patient Square Capital has completed its $2.6 billion acquisition of Premier, Inc. Premier's common stock will cease trading and be delisted from Nasdaq on November 25, 2025.
Why It Matters
Premier's acquisition by Patient Square Capital signals a significant shift in the health care sector, potentially impacting stock valuations and investment strategies in the industry.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About PINC Stock
What is Premier Inc.'s (PINC) stock forecast for 2026?
Based on our analysis of 17 Wall Street analysts, Premier Inc. (PINC) has a median price target of $28.25. The highest price target is $28.25 and the lowest is $28.25.
Is PINC stock a good investment in 2026?
According to current analyst ratings, PINC has 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $28.26. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PINC stock?
Wall Street analysts predict PINC stock could reach $28.25 in the next 12 months. This represents a 0.0% decrease from the current price of $28.26. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Premier Inc.'s business model?
The company generates revenue by providing integrated data analytics, consulting, and services to healthcare providers. Through its comprehensive offerings, including supply chain services and performance improvement programs, Premier helps healthcare institutions enhance service delivery and reduce costs.
What is the highest forecasted price for PINC Premier Inc.?
The highest price target for PINC is $28.25 from Jessica Tassan at Piper Sandler, which represents a 0.0% decrease from the current price of $28.26.
What is the lowest forecasted price for PINC Premier Inc.?
The lowest price target for PINC is $28.25 from Jessica Tassan at Piper Sandler, which represents a 0.0% decrease from the current price of $28.26.
What is the overall PINC consensus from analysts for Premier Inc.?
The overall analyst consensus for PINC is neutral. Out of 17 Wall Street analysts, 0 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $28.25.
How accurate are PINC stock price projections?
Stock price projections, including those for Premier Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 14, 2026 10:07 AM UTC